NDADENTALSOLUTIONPriority Review
Approved
Aug 1986
Lifecycle
LOE Approaching
Competitive Pressure
45/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 8h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PERIDEX is a chlorhexidine gluconate oral rinse approved in 1986 for dental use. It is an antimicrobial solution used to reduce bacterial plaque and gingivitis in oral care settings. The drug works by disrupting bacterial cell membranes in the oral cavity.
LOE Approaching
Mature product approaching loss of exclusivity with moderate competitive pressure (45/100), suggesting contracting team and focus on generic transition strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PERIDEX offers experience managing a mature, LOE-facing product with emphasis on market access, generic competition strategy, and customer retention. Roles focus on defending market share and optimizing profitability in a commoditized category rather than innovation or expansion.
Brand ManagerSales Representative
Worked on PERIDEX at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.